MPD: List measures where strain FVB/NJ is an outlier

List measures where FVB/NJ is an outlier

Click on pulldowns below to see FVB/NJ means with summary statistic tooltips.
Within each pulldown, the "up" and "down" triangles indicate when this strain is an outlier.
You can also download all phenotypes for this strain and sort by Z score in Excel.

Sort/ Pick	Data set	Procedure / Protocol	Treatment	Phenotype Measure / Variable (click to view)	Panel	No. of Strains	Sex	Age	Sample Size (Avg)	Year
Bolivar1:13	Bolivar1	open field test	(none)	vertical activity (beam breaks), 5 min test in dark [n] vert_act 63413 day 1 day 2 day 3	inbred	10	both	8-14wks	N=12	2000

Bolivar1:16	Bolivar1	open field test	(none)	number of vertical movement episodes, 5 min test in dark [n] vert_bouts 63416 day 1 day 2 day 3	inbred	10	both	8-14wks	N=12	2000

Bolivar1:19	Bolivar1	open field test	(none)	percentage of time spent vertical, 5 min test in dark [%] vert_time_pct 63419 day 1 day 2 day 3	inbred	10	both	8-14wks	N=12	2000

Bolivar1:46	Bolivar1	open field test	(none)	distance traveled in center, 5 min test in dark [cm] center_dist 63446 day 1 day 2 day 3	inbred	10	both	8-14wks	N=12	2000

Bolivar3:7	Bolivar3	monitoring system	(none)	percentage of time spent sniffing, 30 min test, study 2 [%] sniffing_time_pct 64207	inbred	7	m	8-12wks	N=12	2007

Bolivar3:9	Bolivar3	monitoring system	(none)	percentage of time spent on negative social interactions, 30 min test, study 2 [%] neg_social_pct 64209	inbred	7	m	8-12wks	N=12	2007

Bolivar3:12	Bolivar3	monitoring system	(none)	percentage of time spent on social activity, 30 min test, study 2 [%] social_time_study2_pct 64212	inbred	7	m	8-12wks	N=12	2007

Brown1:34	Brown1	elevated zero maze	(none)	total head-dips [n] headip_EZM 9434	inbred	13	both	10wks	N=9	2004

Brown2:5	Brown2	Morris water maze	(none)	acquistion training mean distance traveled to find hidden platform, day 3 [cm] acq_dist_d3 22505	inbred	14	both	10-18wks	N=9	2004

Brown2:6	Brown2	Morris water maze	(none)	reversal training mean distance traveled to find hidden platform, day 3 [cm] rev_dist_d3 22506	inbred	14	both	10-18wks	N=9	2004

Brown2:7	Brown2	Morris water maze	(none)	acquisition training mean velocity, day3 [cm/s] acq_vel_d3 22507	inbred	14	both	10-18wks	N=9	2004

Brown2:8	Brown2	Morris water maze	(none)	reversal training mean velocity, day 3 [cm/s] rev_vel_d3 22508	inbred	14	both	10-18wks	N=9	2004

Brown2:11	Brown2	Barnes circular maze	(none)	acquisition training mean errors [n] acq_err 22511 day1 day4	inbred	13	both	10-18wks	N=12	2004

Brown2:13	Brown2	Barnes circular maze	(none)	reversal training mean errors [n] rev_err 22513 day1 day4	inbred	13	both	10-18wks	N=12	2004

Brown2:19	Brown2	Barnes circular maze	(none)	probe trial correct quadrant total entries [n] probe_corr_ent 22519	inbred	13	both	10-18wks	N=11	2004

Brown2:37	Brown2	olfactory discrimination task	(none)	total time spent digging [s] dig_tot 22537	inbred	13	both	10-18wks	N=12	2004

Brown2:43	Brown2	Morris water maze	(none)	probe trial duration, correct quadrant [s] probe_quad_corr 22543	inbred	14	both	10-18wks	N=10	2004

Brown2:44	Brown2	Morris water maze	(none)	probe trial percent time, correct quadrant [%] MWMprobe_corr_pct 22544	inbred	14	both	10-18wks	N=10	2004

CGDpheno1:25	CGDpheno1	complete blood count	(none)	hematocrit (HCT) [%] HCT 31825	inbred w/CC8	72	both	11wks	N=7	2009

CGDpheno1:32	CGDpheno1	complete blood count	(none)	hemoglobin concentration distribution width (HDW) [g/dL] HDW 31832	inbred w/CC8	72	both	11wks	N=7	2009

Crabbe1:7	Crabbe1	grid test	ethanol	grid habituation, missteps per cm [n/cm] grid_ataxia 15407 dose (g/kg): control 1.5 2.0 2.5	inbred	8	both	8-16wks	N=12	2003

Crabbe3:15	Crabbe3	rotarod	ethanol	latency to fall, fixed speed 6 rpm rotarod [s] FS_6rpm_EtOH 15815 dose (g/kg) 1 2 3	inbred	9	both	9-17wks	N=3	2003

Crabbe5:3	Crabbe5	parallel rod floor test	ethanol	motor incoordination, errors over distance traveled, 1.6mm rod, 6mm space [n/cm] err 19603 day1 control day2 control day3 ethanol	inbred	8	both	7-14wks	N=6	2005

Crowley1:17	Crowley1	open field test	haloperidol	vertical activity, beam breaks, 60 min test [n] vertical_act 39417 day: 0 30 60 120	inbred w/CC8	27	m	9-28wks	N=6	2012

Crowley1:21	Crowley1	open field test	haloperidol	repetitive behavior, breaking of same beam, 60 min test [n] stereotypy 39421 day: 0 30 60 120	inbred w/CC8	27	m	9-28wks	N=6	2012

DiPetrillo1:2	DiPetrillo1	urinalysis	(none)	creatinine (urine CREA) [mg/dL] CREA 46002	inbred w/CC7	34	m	10wks	N=13	2012

Donahue18:1	Donahue18	body weight	(none)	percent increase in maternal body weight during pregnancy to E14.5 days [%] pregnancy_load 44401	inbred	15	f	6-8wks	N=15	2010

Flaherty1:5	Flaherty1	elevated zero maze	(none)	duration in open quadrants [s] open 11805 total q2 q4	inbred	8	both	8-9wks	N=20	2001

Flaherty1:13	Flaherty1	elevated zero maze	(none)	percentage of time in open quadrants [%] pct_open 11813 both q2 q4	inbred	8	both	8-9wks	N=20	2001

Graubert1:17	Graubert1	histopathology	ENU	lung carcinoma frequency rate [score] carcinoma_lung 11617 control ENU	inbred	20	both	13-68wks	N=6	2006

Graubert1:18	Graubert1	histopathology	ENU	lymphoid tumor frequency rate [score] lymphoid_tumor 11618 control ENU	inbred	20	both	13-68wks	N=6	2006

Hadsell2:2	Hadsell2	mineral quantification	(none)	milk copper (Cu) concentration [µM] copper 110060	inbred	31	f	14-20wks	N=8	2018

Harrill1:21	Harrill1	metabolic panel	isoniazid	alanine transaminase (serum ALT) [IU/L] ALT 39521 control isoniazid	inbred	34	f	8-10wks	N=4	2011

HMDPpheno2:1	HMDPpheno2	lipid profile	(none)	HDL cholesterol (plasma HDL) [mg/dL] HDL 46401	HMDP w/par	99	m	16wks	N=7	2010

HMDPpheno2:3	HMDPpheno2	lipid profile	(none)	unesterified cholesterol (plasma CHOL) [mg/dL] CHOL_un 46403	HMDP w/par	99	m	16wks	N=7	2010

HMDPpheno2:4	HMDPpheno2	lipid profile	(none)	total cholesterol (plasma CHOL) [mg/dL] CHOL_tot 46404	HMDP w/par	99	m	16wks	N=7	2010

Jax5:4	Jax5	colony observation	(none)	number of pups born per litter [n] born 31404	inbred	35	f	6-40wks	N=184	2009

Jax5:5	Jax5	colony observation	(none)	number of pups weaned per litter [n] wean 31405	inbred	35	f	6-40wks	N=184	2009

Jax5:7	Jax5	colony observation	(none)	total number of pups born per dam [n] born_total 31407	inbred	35	f	6-40wks	N=46	2009

Jax5:8	Jax5	colony observation	(none)	mean number of pups born based on mean number of litters per dam [n] born_mean 31408	inbred	35	f	6-40wks	N=46	2009

Jax5:9	Jax5	colony observation	(none)	total number of pups weaned per dam [n] wean_total 31409	inbred	35	f	6-40wks	N=46	2009

Jax5:10	Jax5	colony observation	(none)	mean number of pups weaned based on mean number of litters per dam [n] wean_mean 31410	inbred	35	f	6-40wks	N=46	2009

Jax5:12	Jax5	colony observation	(none)	total pups weaned per dam over mean interval between litters, adjusted for biological parameters [n/d] fecundity_index 31412	inbred	35	f	6-40wks	N=44	2009

Jaxpheno4:50	Jaxpheno4	complete blood count	(none)	platelet count (PLT; units per volume x 10³) [n/µL] PLT 22950 age 8wks age 16wks	inbred	11	both		N=17	2006

Kliethermes1:2	Kliethermes1	monitoring system	(none)	number of rears in a task to assess novelty seeking, 30 min test [n] num_rears_MS 59902	inbred	14	both	8wks	N=6	2006

Kliethermes1:3	Kliethermes1	monitoring system	(none)	time spent rearing in a task to assess novelty seeking, 30 min test [s] time_rears_MS 59903	inbred	14	both	8wks	N=6	2006

Kliethermes1:4	Kliethermes1	monitoring system	(none)	residual score from regression of rears on horizontal activity in a task to assess novelty seeking, 30 min test [score] regression_MS 59904	inbred	14	both	8wks	N=6	2006

Korstanje1:11	Korstanje1	urinalysis	(none)	creatinine (urine CREA) [mg/dL] CREA 29711 12mo 18mo 24mo	inbred	30	both		N=7	2008

Kumar4:13	Kumar4	gait analysis	(none)	limb duty factor, hind paws (keypoints), variance limb_duty_factor_var 114443	inbred w/CC8	62	both	10-20wks	N=19	2021

Kumar4:22	Kumar4	gait analysis	(none)	distance right hind paw keypoint travels past previous left hind paw keypoint strike, variance [cm] step_length1_var 114452	inbred w/CC8	62	both	10-20wks	N=19	2021

Kumar4:25	Kumar4	gait analysis	(none)	distance left hind paw keypoint travels past the right hind paw keypoint strike, variance [cm] step_length2_var 114455	inbred w/CC8	62	both	10-20wks	N=19	2021

Kumar4:31	Kumar4	gait analysis	(none)	distance left hind paw keypoint travels for a stride, from toe-off to foot-strike, variance [cm] stride_length_var 114461	inbred w/CC8	62	both	10-20wks	N=19	2021

Loos2:11	Loos2	home cage monitoring	(none)	dark-light index describing difference in cumulative activity duration between light and dark phase, over 3 days of testing [ratio] activity_dur_DKLT_index 54011	inbred w/CC7	11	m	8-12wks	N=40	2016

Loos2:24	Loos2	home cage monitoring	(none)	change in activity proportion: response to phase onset, over 3 days of testing activity_response 54024 dark light	inbred w/CC7	11	m	8-12wks	N=40	2016

Loos2:36	Loos2	home cage monitoring	(none)	change in OnShelter zone duration: anticipation of phase change, over 3 days of testing onshelter_anticipation 54036 dark light	inbred w/CC7	11	m	8-12wks	N=35	2016

Maurer1:17	Maurer1	ECG	atenolol, isoproterenol	amplitude of Q-wave [mV] Q_amp 33217 control atenolol 10mg isoprot 1mg isoprot 10mg	inbred	23	m	7-13wks	N=9	2009

Maurer1:78	Maurer1	organ weights	atenolol, isoproterenol	atria weight [mg] atria_wt 33278 control atenolol 10mg isoprot 1mg isoprot 10mg	inbred	23	m	7-13wks	N=10	2009

Metten1:1	Metten1	open field test	ethanol	line crossings, 2.75 g/kg i.p. [n] line_doseA 16501 pre-injection 10min after injection 30min after	inbred	9	both	8-11wks	N=4	2004

Paigen1:19	Paigen1	histopathology	high-fat diet	gallbladder, presence of stones (score: 1=present, 0=absent) [score] st_pres 2919	inbred	43	both	15-19wks	N=9	2000

Paigen2:6	Paigen2	lipid profile	high-fat diet	total cholesterol (plasma) [mg/dL] CHOL 9906 baseline after 17wks on diet Δchange	inbred w/CC7	42	both	7-9wks	N=9	2002

Peters4:57	Peters4	complete blood count	(none)	hematocrit (HCT) [%] pctHCT 24357 6mo 12mo 18mo 24mo	inbred	30	both		N=7	2007

Peters4:61	Peters4	complete blood count	(none)	hemoglobin (HGB) [g/dL] HGB 24361 6mo 12mo 18mo 24mo	inbred	30	both		N=7	2007

Peters4:93	Peters4	complete blood count	(none)	platelet count (PLT; units per volume x 10³) [n/µL] Plt 24393 6mo 12mo 18mo 24mo	inbred	30	both		N=7	2007

Rusyn2:49	Rusyn2	organ weights	(none)	liver weight as percent of body weight, t=24h (local parameter) [%] LW_adj24_tce 36149	inbred	16	m	7wks	N=3	2010

Schwartz2:21	Schwartz2	bronchoalveolar lavage assessment	ovalbumin	alveolar lymphocytes (percentage of total lavage cells), pre-challenge [%] pctLYM0 9821 pre-test: control OVA-sensitized	inbred	8	m	6-8wks	N=3	2001

Seburn1:23	Seburn1	monitoring system	(none)	total activity, beam breaks per min, 3 day test [n/min] tot 9223 daily light dark	inbred	16	both	7-9wks	N=8	2001

Seburn1:26	Seburn1	monitoring system	(none)	ambulatory activity, beam breaks per min, 3 day test [n/min] aa 9226 daily light dark	inbred	16	both	7-9wks	N=8	2001

Shin1:6	Shin1	elevated plus maze	(none)	percent time spent in open arms for 5 min [%] EPM_open 54506	inbred	11	m	12-14wks	N=13	2016

Spijker2:25	Spijker2	elevated plus maze	(none)	entries into open arms, 5 min test [n] entry_open_EPM 44025	inbred	12	m	6wks	N=12	2009

Spijker2:29	Spijker2	choice serial reaction time task	(none)	impulsivity, 25 min test [%] impulsivity 44029	inbred	12	m	6wks	N=12	2009

Tarantino1:11	Tarantino1	open field test	cocaine	average velocity, 30 min test [cm/s] vel 45926 baseline (day 2) treated (day 3) difference	inbred	45	m	8-11wks	N=18	2015

Thomsen1:1	Thomsen1	open field test	cocaine	total activity, test 1, 3h test [n] activ_cocaine1 40701 baseline dose mg/kg i.p.: 3 10 18 32 56	inbred	15	both	8-10wks	N=8	2011

Thomsen1:7	Thomsen1	open field test	cocaine	total activity, test 2, 3h test [n] activ_cocaine2 40707 baseline dose mg/kg i.p.: 3 10 32	inbred	15	both	8-10wks	N=8	2011

Thomsen2:1	Thomsen2	open field test	R-6-Br-APB	total activity, dose response to D1 agonist, 3h test [n] activ_D1 40801 baseline dose mg/kg i.p. 0.03 0.32 3.2 5.6	inbred	15	both	8-10wks	N=8	2011

Thomsen2:6	Thomsen2	open field test	quinelorane	total activity, dose response to D2 agonist, 3h test [n] activ_D2 40806 baseline dose mg/kg i.p. 0.03 0.32 3.2 5.6	inbred	15	both	8-10wks	N=8	2011

Vinyard1:2	Vinyard1	bone dimensions	(none)	masseter attachment ratio [ratio] masseter_attach_ratio 30402	inbred	21	both	9-12wks	N=10	2009

Wiltshire3:16	Wiltshire3	biomarker quantification	fluoxetine	cerebral cortex FOS (c-fos), relative fluorescence intensity FOS 38116 control fluoxetine change index	inbred	30	m	10-11wks	N=3	2011

Yuan3:26	Yuan3	metabolic panel	(none)	iron (serum Fe) [mmol/L] Fe 24426 6mo 12mo 18mo	inbred	32	both		N=7	2008

Yuan3:41	Yuan3	metabolic panel	(none)	potassium (serum K) [mmol/L] K 24441 6mo 12mo 18mo	inbred	32	both		N=7	2008

Zheng1:2	Zheng1	tympanometry	(none)	outer ear canal equivalent volume, right ear [mL] Rvolume 29802	inbred	61	both	5-68wks	N=4	2008

Zheng1:6	Zheng1	tympanometry	(none)	outer ear canal equivalent volume, left ear [mL] Lvolume 29806	inbred	61	both	5-68wks	N=4	2008

Zimmermann1:9	Zimmermann1	monitoring system	(none)	fine or stationary movement on x-y axis, repeated interruptions of same beam, second day (beam breaks/min) [n/min] fine_act 112172 during light during dark	inbred	30	both	7-15wks	N=11	2020

Zimmermann1:11	Zimmermann1	monitoring system	(none)	ambulatory movement on x-y axis, consecutive interruptions of different beams, second day (beam breaks/min) [n/min] amb_act 112174 during light during dark	inbred	30	both	7-15wks	N=11	2020

Zimmermann1:13	Zimmermann1	monitoring system	(none)	rearing movement, number of z-axis beam breaks, second day (beam breaks/min) [n/min] rearing_act 112176 during light during dark	inbred	30	both	7-15wks	N=11	2020

List measures where FVB/NJ is an outlier

Filter Table Results